Pediatrics Medical News about daunorubicin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol
Pediatric Blood & Cancer, 09/11/09

Hempel G et al. – Patients aged <6 months experienced more infections in the induction phase than the group aged 6–12 months at diagnosis. Other toxicities were similar in both groups. The authors observed no indication of an age–dependency in the pharmacokinetics of daunorubicin.

<< Previous
Antipyretic Agents for Preventing Recurrences of Febrile Seizures

Next >>
Interactions between antiepileptic and chemotherapeutic drugs in...